New Bipartisan Bill Would Let Cannabis Companies List on Major Stock Exchanges Like Nasdaq and NYSE

The CLIMB Act is making another run through Congress, and it could be a game-changer for how our favorite cannabis brands operate. This bipartisan bill aims to let marijuana companies list on major stock exchanges like the NYSE and Nasdaq, finally giving them a seat at the big table on Wall Street. Beyond just stocks, it creates a safe harbor for the essential services these businesses need—everything from accounting and insurance to advertising and legal aid—protecting those providers from federal backlash.

While we're still waiting on federal rescheduling to cross the finish line, this legislation tackles the "green tape" that keeps the industry in a financial chokehold. For the average toker, this matters because more investment and better business protections mean more stable, professional, and accessible dispensaries. When cannabis companies can bank and trade like normal businesses, the savings and innovation eventually trickle down to the quality and variety on the shelves. It’s about time the industry was treated with the legitimacy it deserves, and this bill is a massive step toward that reality.